Capehorn MS, Catarig A-M, Furberg JK, Janez A, Price HC, Tadayon S, et al
Semaglutide: Column: C18 column
Infections: vulvovaginal candidiasis, bacterial vaginosis, vulvovaginitis Comparative observational signal (protective association): In a phenome-wide association study comparing people with type 2 diabetes prescribed GLP-1 receptor agonists vs SGLT2 inhibitors and DPP4 inhibitors (NIH All of Us cohort, Jan 2018Oct 2023), semaglutide prescription was associated with reduced risk of diagnoses including candidiasis of vulva and vagina and inflammatory disease of cervix, vagina, and vulva compared with SGLT2 inhibitors
Glucagon-like peptide-1 (GLP-1) receptor agonists like Semaglutide are among the promising options for managing type 2 diabetes and weight-related concerns
Coders should NOT apply this code without provider documentation, and should query when the record suggests DM may be in remission based on clinical indicators alone
That's why a new model of care has emerged, one that puts the patient back in control
